-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Author: Bai Yu
A few days ago, Hengrui Pharmaceuticals issued an announcement stating that the company has been approved for inhalation sevoflurane for imitation of the 4 types of applications and is deemed to have been reviewed.
Drug-related situation
Data show that sevoflurane for inhalation enters the human body through the respiratory tract in the form of volatile gas to form anesthesia, which is suitable for the induction and maintenance of general anesthesia for adults and children
Sales of sevoflurane for terminal inhalation in public medical institutions in China in recent years (unit: 100 million yuan)
Source: Mi Nei.
Sevoflurane for inhalation was developed by Maruishi Pharmaceutical Co.
Source: One-click search on Mi Nei.
Prior to this, there were five domestic manufacturers of sevoflurane for inhalation, including Maruishi Pharmaceutical Co.
Up to now, Hengrui Medicine has invested about 13.
Source: Listed company announcements, Mi Nei.